Second Trimester Amniocentesis Is Not a Risk Factor for Very Low Birth Weight and Extremely Low Birth Weight

Objectives. To assess the risk of very low birth weight (VLBW) and extremely low birth weight (ELBW) attributable to second trimester amniocentesis. Methods. Records of 4,877 consecutive amniocentesis, performed between 1997 and 2003, were analyzed. Only VLBW and ELBW in the study population (exposed) and in the control group (unexposed) were evaluated. Comparisons were made between the amniocentesis group versus nonexposed. Odds ratios (OR) and 95% confidence intervals (95% CI) were calculated for VLBW and ELBW classes. Results. In the study population, the VLBW were 35 (0.71%) and the ELBW were 20 (0.41%). In the control group, the VLBW were 220 (0.67%) and the ELBW were 112 (0.34%). The Odds ratios of the VLBW between the study and the control group did not show any statistical significant risk (OR = 1.07, 95% CI = 0.72–1.54). Also in ELBW odds ratios between study and control group were not statistically significant (OR = 1.20, 95% CI = 0.7–1.95). Conclusions. No effect of the second trimester amniocentesis was noted on VLBW and ELBW.

[1]  Aaas News,et al.  Book Reviews , 1893, Buffalo Medical and Surgical Journal.

[2]  P. Sritipsukho,et al.  Survival and outcome of very low birth weight infants born in a university hospital with level II NICU. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[3]  A. Ranzi,et al.  Age‐specific risk of fetal loss post second trimester amniocentesis: analysis of 5043 cases , 2007, Prenatal diagnosis.

[4]  M. Orzalesi,et al.  Geographic variations in outcome of very low birth weight infants in Italy , 2007, Acta paediatrica.

[5]  E. Draper,et al.  Extremely Growth-Retarded Infants: Is There a Viability Centile? , 2006, Pediatrics.

[6]  B. Dallapiccola,et al.  Genetic testing in Italy, year 2004 , 2006, European Journal of Human Genetics.

[7]  Y. Burns,et al.  The association between early minor motor difficulties in extreme low birth weight infants and school age attentional difficulties. , 2006, Early human development.

[8]  A. Rønnestad,et al.  Early Death, Morbidity, and Need of Treatment Among Extremely Premature Infants , 2005, Pediatrics.

[9]  O. Axelsson,et al.  Infant morbidity following amniocentesis and chorionic villus sampling for prenatal karyotyping , 2005, BJOG: an International Journal of Obstetrics and Gynaecology.

[10]  S. Donati,et al.  Genetic amniocentesis: a risk factor for preterm delivery? , 2003, European journal of obstetrics, gynecology, and reproductive biology.

[11]  W. Piyamongkol,et al.  Amniocentesis-Related Fetal Loss: A Cohort Study , 1998 .

[12]  W. Piyamongkol,et al.  Amniocentesis‐Related Fetal Loss: A Cohort Study , 1998, Obstetrics and gynecology.

[13]  O. Axelsson,et al.  A PROSPECTIVE COMPARATIVE STUDY ON TRANSABDOMINAL CHORIONIC VILLUS SAMPLING AND AMNIOCENTESIS PERFORMED AT 10–13 WEEKS' GESTATION , 1997 .

[14]  K. Nicolaides,et al.  Comparison of chorionic villus sampling and amniocentesis for fetal karyotyping at 10-13 weeks' gestation , 1994, The Lancet.

[15]  A. Ghiatas.  Midtrimester amniocentesis for prenatal diagnosis. , 1984, The Journal of the Medical Society of New Jersey.

[16]  Midtrimester amniocentesis for prenatal diagnosis. Safety and accuracy. , 1976, JAMA.

[17]  E. Gerdts.  Letter: Cervical cancer and gonorrhoea. , 1974, Lancet.